Trademark search for:

NTANGIQ

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2013-03-21 — Application filed
2013-03-25 — Application filed
2013-03-26 — Application filed
2013-05-08 — Assigned to examiner
2013-05-14 — Priority action written
2013-05-14 — Priority action e-mailed
2013-05-14 — Notification of priority action e-mailed
2013-06-03 — Examiners amendment -written
2013-06-03 — Examiners amendment e-mailed
2013-06-03 — Notification of examiners amendment e-mailed
2013-06-03 — Examiner's amendment entered
2013-06-03 — Assigned to lie
2013-06-07 — Approved for pub - principal register
2013-06-09 — Law office publication review completed
2013-06-26 — Notification of notice of publication e-mailed
2013-07-16 — Published for opposition
2013-07-16 — Official gazette publication confirmation e-mailed
2013-09-10 — Noa e-mailed - sou required from applicant
2014-01-16 — Sou teas extension received
2014-01-16 — Sou extension 1 filed
2014-01-16 — Sou extension 1 granted
2014-01-18 — Notice of approval of extension request e-mailed
2014-10-13 — Application abandoned
2014-10-13 — Final status recorded
2014-10-14 — Application abandoned

Owner Information

Amgen Inc.
Thousand Oaks , CA

Correspondent

MARK I. FELDMAN DLA PIPER LLP (US)
PO BOX 64807
CHICAGO, IL 60664-0807
UNITED STATES

Filing Details

Filing Date:
2013-03-21

Status Date:
2014-10-13

Category:
Pharmaceuticals

Filing Year:
2013

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.